These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23151826)

  • 1. Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.
    Foroutan P; Murray ME; Fujioka S; Schweitzer KJ; Dickson DW; Wszolek ZK; Grant SC
    Radiology; 2013 Jan; 266(1):280-8. PubMed ID: 23151826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
    Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
    BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron accumulation in the oculomotor nerve of the progressive supranuclear palsy brain.
    Lee H; Lee MJ; Kim EJ; Huh GY; Lee JH; Cho H
    Sci Rep; 2021 Feb; 11(1):2950. PubMed ID: 33536537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.
    Massey LA; Miranda MA; Al-Helli O; Parkes HG; Thornton JS; So PW; White MJ; Mancini L; Strand C; Holton J; Lees AJ; Revesz T; Yousry TA
    Neuroimage Clin; 2017; 13():154-163. PubMed ID: 27981030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.
    Fermin-Delgado R; Roa-Sanchez P; Speckter H; Perez-Then E; Rivera-Mejia D; Foerster B; Stoeter P
    Clin Neuroradiol; 2013 Mar; 23(1):11-5. PubMed ID: 22258188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.
    Drayer BP; Olanow W; Burger P; Johnson GA; Herfkens R; Riederer S
    Radiology; 1986 May; 159(2):493-8. PubMed ID: 3961182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
    Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
    Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism.
    Yamamoto T; Kawamura J; Hashimoto S; Nakamura M; Iwamoto H; Kobashi Y; Ichijima K
    J Neurol Sci; 1991 Jan; 101(1):98-106. PubMed ID: 1709202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of R2 with total iron concentration in the brains of rhesus monkeys.
    Hardy PA; Gash D; Yokel R; Andersen A; Ai Y; Zhang Z
    J Magn Reson Imaging; 2005 Feb; 21(2):118-27. PubMed ID: 15666406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.
    Eckert T; Sailer M; Kaufmann J; Schrader C; Peschel T; Bodammer N; Heinze HJ; Schoenfeld MA
    Neuroimage; 2004 Jan; 21(1):229-35. PubMed ID: 14741660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy: MRI and pathological findings.
    Yagishita A; Oda M
    Neuroradiology; 1996 May; 38 Suppl 1():S60-6. PubMed ID: 8811682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An autopsy case of "progressive supranuclear palsy" without psychiatric or neurological signs].
    Oshima K; Tsuchiya K; Iritani S; Niizato K; Akiyama H; Arai H; Ikeda K
    No To Shinkei; 2004 Feb; 56(2):157-61. PubMed ID: 15098361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain regional iron contents in progressive supranuclear palsy.
    Lee SH; Lyoo CH; Ahn SJ; Rinne JO; Lee MS
    Parkinsonism Relat Disord; 2017 Dec; 45():28-32. PubMed ID: 28982612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative susceptibility mapping from basal ganglia and related structures: correlation with disease severity in progressive supranuclear palsy.
    Krishnan S; George SS; Radhakrishnan V; Raghavan S; Thomas B; Thulaseedharan JV; Puthenveedu DK
    Acta Neurol Belg; 2024 Feb; 124(1):151-160. PubMed ID: 37580639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra.
    Sakai K; Yamada M
    Neuropathology; 2011 Feb; 31(1):77-81. PubMed ID: 20573028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.